+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Nutrigenomics Market by Application and Geography - Forecast and Analysis 2020-2024 - Product Image

Nutrigenomics Market by Application and Geography - Forecast and Analysis 2020-2024

  • ID: 4856389
  • Report
  • October 2019
  • Region: Global
  • 139 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • BASF SE
  • Cell-Logic
  • Danone
  • DSM
  • Genova Diagnostics Inc.
  • GX Sciences Inc.
  • MORE
Global Nutrigenomics Market: About this market
The nutrigenomics market analysis considers sales from obesity, cardiovascular diseases, and cancer research applications. Our study also finds the sales of nutrigenomics in Asia, Europe, North America, and ROW. In 2019, the obesity segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing number of obese people will play a significant role in the obesity segment to maintain its market position. Also, our global nutrigenomics market report looks at factors such as increasing cost of medical treatment, growing investments by government and private stakeholders, and rising number of health-conscious people. However, high cost and unavailability of user-friendly tools for easy interpretation of data, low awareness of nutrigenomic technologies in emerging economies, and lack of skilled professionals may hamper the growth of the nutrigenomics industry over the forecast period.

Global Nutrigenomics Market: Overview

The increasing cost of medical treatment
There is an increase in the overall healthcare costs due to the rising prevalence of disease and increasing expenditure on hospitals, medicine, and treatment. The medical expenditure by patients is also increasing because branded drugs are expensive. This is driving them to consume fortified dairy products and dietary supplements to prevent health issues and stay healthy. Fortified dairy and dietary supplements contain nutrients such as polyphenols, carotenoids, and vitamins that are based on nutrigenomics. Thus, this will boost the dependence on nutrigenomics, which will lead to the expansion of the global nutrigenomics market at a CAGR of over 11% during the forecast period.

Increasing prevalence of obesity
The increase in rich, fatty, and high-calorie food and the decrease in physical activities have led to the increasing incidence of obesity worldwide. With the growing rate of obesity, the burden on public health is increased, leading to more patients opting for nutrigenetic testing to aid in obesity management. Obesity can lead to several diseases, including high blood pressure, diabetes, gallbladder disease, sleep apnea, kidney disease, cancer, osteoarthritis, cardiac disease, and breathing problems. Nutrigenomics help in identifying the nutrients and gene interaction and in achieving long-term weight loss in a sustainable way. This development is expected to have a positive impact on the overall market growth.

Competitive Landscape
With the presence of a few major players, the global nutrigenomics market is concentrated. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading nutrigenomics manufacturers, that include BASF SE, Cell-Logic, Danone, DSM, Genova Diagnostics Inc., GX Sciences Inc., Metagenics Inc., Nutrigenomix Inc., Unilever Group, and Xcode Life Sciences Private Limited.

Also, the nutrigenomics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • BASF SE
  • Cell-Logic
  • Danone
  • DSM
  • Genova Diagnostics Inc.
  • GX Sciences Inc.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value Chain Analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market Outlook
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY APPLICATION
  • Market segmentation by application
  • Comparison by application
  • Obesity - Market size and forecast 2019-2024
  • Cardiovascular diseases - Market size and forecast 2019-2024
  • Cancer research - Market size and forecast 2019-2024
  • Market opportunity by application
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • Rising demand for training in and awareness of nutrigenomics technologies
  • Increasing approval of grants
  • Increasing prevalence of obesity
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • BASF SE
  • Cell-Logic
  • Danone
  • DSM
  • Genova Diagnostics Inc.
  • GX Sciences Inc.
  • Metagenics Inc.
  • Nutrigenomix Inc.
  • Unilever Group
  • Xcode Life Sciences Private Limited
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits
Exhibit 01: Global healthcare market
Exhibit 02: Segments of global healthcare market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendor offerings
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Application - Market share 2019-2024 (%)
Exhibit 19: Comparison by application
Exhibit 20: Obesity - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Obesity - Year-over-year growth 2020-2024 (%)
Exhibit 22: Cardiovascular diseases - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Cardiovascular diseases - Year-over-year growth 2020-2024 (%)
Exhibit 24: Cancer research - Market size and forecast 2019-2024 ($ millions)
Exhibit 25: Cancer research - Year-over-year growth 2020-2024 (%)
Exhibit 26: Market opportunity by application
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2019-2024 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 31: North America - Year-over-year growth 2020-2024 (%)
Exhibit 32: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 36: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 37: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: BASF SE - Vendor overview
Exhibit 47: BASF SE - Business segments
Exhibit 48: BASF SE - Organizational developments
Exhibit 49: BASF SE - Geographic focus
Exhibit 50: BASF SE - Segment focus
Exhibit 51: BASF SE - Key offerings
Exhibit 52: Cell-Logic - Vendor overview
Exhibit 53: Cell-Logic - Product segments
Exhibit 54: Cell-Logic - Key offerings
Exhibit 55: Danone - Vendor overview
Exhibit 56: Danone - Business segments
Exhibit 57: Danone - Organizational developments
Exhibit 58: Danone - Geographic focus
Exhibit 59: Danone - Segment focus
Exhibit 60: Danone - Key offerings
Exhibit 61: DSM - Vendor overview
Exhibit 62: DSM - Business segments
Exhibit 63: DSM - Organizational developments
Exhibit 64: DSM - Segment focus
Exhibit 65: DSM - Key offerings
Exhibit 66: Genova Diagnostics Inc. - Vendor overview
Exhibit 67: Genova Diagnostics Inc. - Product segments
Exhibit 68: Genova Diagnostics Inc. - Organizational developments
Exhibit 69: Genova Diagnostics Inc. - Key offerings
Exhibit 70: GX Sciences Inc. - Vendor overview
Exhibit 71: GX Sciences Inc. - Product segments
Exhibit 72: GX Sciences Inc. - Organizational developments
Exhibit 73: GX Sciences Inc. - Key offerings
Exhibit 74: Metagenics Inc. - Vendor overview
Exhibit 75: Metagenics Inc. - Product segments
Exhibit 76: Metagenics Inc. - Key offerings
Exhibit 77: Nutrigenomix Inc. - Vendor overview
Exhibit 78: Nutrigenomix Inc. - Product segments
Exhibit 79: Nutrigenomix Inc. - Key offerings
Exhibit 80: Unilever Group - Vendor overview
Exhibit 81: Unilever Group - Business segments
Exhibit 82: Unilever Group - Organizational developments
Exhibit 83: Unilever Group - Geographic focus
Exhibit 84: Unilever Group - Segment focus
Exhibit 85: Unilever Group - Key offerings
Exhibit 86: Xcode Life Sciences Private Limited - Vendor overview
Exhibit 87: Xcode Life Sciences Private Limited - Product segments
Exhibit 88: Xcode Life Sciences Private Limited - Key offerings
Exhibit 89: Validation techniques employed for market sizing
Exhibit 90: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • BASF SE
  • Cell-Logic
  • Danone
  • DSM
  • Genova Diagnostics Inc.
  • GX Sciences Inc.
  • MORE
The following companies as the key players in the global nutrigenomics market: BASF SE, Cell-Logic, Danone, DSM, Genova Diagnostics Inc., GX Sciences Inc., Metagenics Inc., Nutrigenomix Inc., Unilever Group, and Xcode Life Sciences Private Limited.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing prevalence of obesity.”

According to the report, one of the major drivers for this market is the increasing cost of medical treatment.

Further, the report states that one of the major factors hindering the growth of this market is the lack of skilled professionals.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
4 of 5
  • BASF SE
  • Cell-Logic
  • Danone
  • DSM
  • Genova Diagnostics Inc.
  • GX Sciences Inc.
  • Metagenics Inc.
  • Nutrigenomix Inc.
  • Unilever Group
  • Xcode Life Sciences Private Limited.
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll